Related references
Note: Only part of the references are listed.Whole-body magnetic resonance imaging for prostate cancer assessment: Current status and future directions
Sandy Van Nieuwenhove et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2022)
aPROMISE: A Novel Automated PROMISE Platform to Standardize Evaluation of Tumor Burden in 18F-DCFPyL Images of Veterans with Prostate Cancer
Nicholas Nickols et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter-expressing tumour
Elin Pauwels et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Impact of68Ga-NOTA-MAL-MZHER2 PET imaging in advanced gastric cancer patients and therapeutic response monitoring
Nina Zhou et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Consensus statements on PSMA PET/CT response assessment criteria in prostate cancer
Stefano Fanti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
PSMA whole-body tumor burden in primary staging and biochemical recurrence of prostate cancer
Allan Santos et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Deep-Learning 18F-FDG Uptake Classification Enables Total Metabolic Tumor Volume Estimation in Diffuse Large B-Cell Lymphoma
Nicolo Capobianco et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Risk stratification in diffuse large B-cell lymphoma using lesion dissemination and metabolic tumor burden calculated from baseline PET/CT
A-S Cottereau et al.
ANNALS OF ONCOLOGY (2021)
Total diffusion volume in MRI vs. total lesion glycolysis in PET/CT for tumor volume evaluation of multiple myeloma
Toshiki Terao et al.
EUROPEAN RADIOLOGY (2021)
Incorporating radiomics into clinical trials: expert consensus on considerations for data-driven compared to biologically driven quantitative biomarkers
Laure Fournier et al.
EUROPEAN RADIOLOGY (2021)
Morphological, functional, and molecular assessment of breast cancer bone metastases by experimental ultrasound techniques compared with magnetic resonance imaging and histological analysis
Henrik Heinen et al.
BONE (2021)
Impact of 18F-FDG PET, PET/CT, and PET/MRI on Staging and Management as an Initial Staging Modality in Breast Cancer A Systematic Review and Meta-analysis
Sangwon Han et al.
CLINICAL NUCLEAR MEDICINE (2021)
[18F]FDG PET/CT quantitative parameters for the prediction of histological response to induction chemotherapy and clinical outcome in patients with localised bone and soft-tissue Ewing sarcoma
Alessio Annovazzi et al.
EUROPEAN RADIOLOGY (2021)
Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer
Shimpei Yamamoto et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2021)
Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the Biograph Vision Quadra with the Biograph Vision PET/CT
Ian Alberts et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients
Nils Martin Bruckmann et al.
EUROPEAN RADIOLOGY (2021)
The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review
Natale Quartuccio et al.
NUCLEAR MEDICINE COMMUNICATIONS (2021)
The promise of artificial intelligence and deep learning in PET and SPECT imaging
Hossein Arabi et al.
PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS (2021)
In Comparison to PSA, Interim Ga-68-PSMA PET/CT Response Evaluation Based on Modified RECIST 1.1 After 2nd Cycle Is Better Predictor of Overall Survival of Prostate Cancer Patients Treated With 177Lu-PSMA
Vikas Prasad et al.
FRONTIERS IN ONCOLOGY (2021)
Concordance between Response Assessment Using Prostate-Specific Membrane Antigen PET and Serum Prostate-Specific Antigen Levels after Systemic Treatment in Patients with Metastatic Castration Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
Sangwon Han et al.
DIAGNOSTICS (2021)
Assessment of volumetric parameters derived from 68Ga-PSMA PET/CT in prostate cancer patients with biochemical recurrence: an institutional experience
Berna Okudan et al.
NUCLEAR MEDICINE COMMUNICATIONS (2021)
Multimodal Bone Metastasis-associated Epidermal Growth Factor Receptor Imaging in an Orthotopic Rat Model
Tobias Baeuerle et al.
RADIOLOGY-IMAGING CANCER (2021)
Molecular imaging and biochemical response assessment after a single cycle of [225Ac]Ac-PSMA-617/[177Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [177Lu]Lu-PSMA-617 monotherapy
Florian Rosar et al.
THERANOSTICS (2021)
Flare phenomenon in prostate cancer: recent evidence on new drugs and next generation imaging
Vincenza Conteduca et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2021)
Simultaneous PET/MRI in the Evaluation of Breast and Prostate Cancer Using Combined Na[18F] F and [18F]FDG: a Focus on Skeletal Lesions
Ida Sonni et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Assessing Radiographic Response to 223Ra with an Automated Bone Scan Index in Metastatic Castration-Resistant Prostate Cancer Patients
Aseem Anand et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis
Tassia Machado Medeiros et al.
EUROPEAN RADIOLOGY (2020)
Inflammation-Based Index and Ga-68-DOTATOC PET-Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with Y-90-DOTATOC
Elin Pauwels et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Quantitative Test-Retest Measurement of 68Ga-PSMA-HBED-CC in Tumor and Normal Tissue
Janet H. Pollard et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer
Bernard H. E. Jansen et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Computed tomography-based skeletal segmentation for quantitative PET metrics of bone involvement in multiple myeloma
Maria E. S. Takahashi et al.
NUCLEAR MEDICINE COMMUNICATIONS (2020)
Role of Baseline and Post-Therapy 18F-FDG PET in the Prognostic Stratification of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated with Radium-223
Matteo Bauckneht et al.
CANCERS (2020)
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping
Alex Zwanenburg et al.
RADIOLOGY (2020)
Molecular Imaging of Bone Metastases and Their Response to Therapy
Gary J. R. Cook et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Visual and quantitative evaluation of [18F]FES and [18F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study
Lemonitsa H. Mammatas et al.
EJNMMI RESEARCH (2020)
Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy-Do Different Software Solutions Deliver Comparable Results?
Philipp E. Hartrampf et al.
JOURNAL OF CLINICAL MEDICINE (2020)
State of the art in total body PET
Stefaan Vandenberghe et al.
EJNMMI PHYSICS (2020)
Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications
Brenda F. Kurland et al.
ONCOLOGIST (2020)
A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies
Junhong Li et al.
ANNALS OF PALLIATIVE MEDICINE (2020)
The clinical efficacy of PSMA PET/MRI in biochemically recurrent prostate cancer compared with standard of care imaging modalities and confirmatory histopathology: results of a single-centre, prospective clinical trial
A. Joshi et al.
CLINICAL & EXPERIMENTAL METASTASIS (2020)
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2020)
Different18F-FDG PET parameters for the prediction of histological response to neoadjuvant chemotherapy in pediatric Ewing sarcoma family of tumors
Gihan El-Hennawy et al.
PEDIATRIC BLOOD & CANCER (2020)
Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone
Michael Kosmin et al.
RADIOLOGY (2020)
Artificial Intelligence and Machine Learning in Nuclear Medicine: Future Perspectives
Robert Seifert et al.
SEMINARS IN NUCLEAR MEDICINE (2020)
Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels
Paola Pricolo et al.
CANCER IMAGING (2020)
Immune Checkpoint Inhibitors in Lung Cancer: Role of Biomarkers and Combination Therapies
Tun Zan Maung et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2020)
Impact of 18F-FDG PET/CT in Staging Patients With Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Francesco Martucci et al.
FRONTIERS IN MEDICINE (2020)
The Evolving Role of FDG-PET/CT in the Diagnosis, Staging, and Treatment of Breast Cancer
Koosha Paydary et al.
MOLECULAR IMAGING AND BIOLOGY (2019)
18F-NaF-PET/CT for the detection of bone metastasis in prostate cancer: a meta-analysis of diagnostic accuracy studies
Sara Sheikhbahaei et al.
ANNALS OF NUCLEAR MEDICINE (2019)
Prediction of early metastatic disease in experimental breast cancer bone metastasis by combining PET/CT and MRI parameters to a Model-Averaged Neural Network
Stephan Ellmann et al.
BONE (2019)
Does whole-body Patlak 18F-FDG PET imaging improve lesion detectability in clinical oncology?
Guillaume Fahrni et al.
EUROPEAN RADIOLOGY (2019)
Can pretreatment 18F-FDG PET tumor texture features predict the outcomes of osteosarcoma treated by neoadjuvant chemotherapy?
Hongjun Song et al.
EUROPEAN RADIOLOGY (2019)
qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using 68Ga-PSMA11 PET/CT
Andrei Gafita et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Assessment of Simplified Methods for Quantification of 18F-FDHT Uptake in Patients with Metastatic Castration-Resistant Prostate Cancer
Gerbrand M. Kramer et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients
Guilherme D. Kolinger et al.
EJNMMI RESEARCH (2019)
Comparison of standardized uptake values between 99mTc-HDP SPECT/CT and 18F-NaF PET/CT in bone metastases of breast and prostate cancer
Samuli Arvola et al.
EJNMMI RESEARCH (2019)
A novel biomarker, active whole skeletal total lesion glycolysis (WS-TLG), as a quantitative method to measure bone metastatic activity in breast cancer patients
Mitsuru Koizumi et al.
ANNALS OF NUCLEAR MEDICINE (2019)
68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer
Clemens Kratochwil et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer
Bernard H. E. Jansen et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Artificial intelligence, machine (deep) learning and radio(geno)mics: definitions and nuclear medicine imaging applications
Dimitris Visvikis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
18F-FES PET/CT Influences the Staging and Management of Patients with Newly Diagnosed Estrogen Receptor-Positive Breast Cancer: A Retrospective Comparative Study with 18F-FDG PET/CT
Cheng Liu et al.
ONCOLOGIST (2019)
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer
Ru Wang et al.
BMC CANCER (2019)
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging
Gurdip K. Azad et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer
Bernhard Grubmueller et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
Contemporary Management of Appendicular Skeletal Metastasis by Primary Tumor Type
Christopher N. Johnson et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2019)
Quantitative implications of the updated EARL 2019 PET-CT performance standards
Andres Kaalep et al.
EJNMMI PHYSICS (2019)
Hybrid Imaging (PET-Computed Tomography/PET-MR Imaging) of Bone Metastases
Christian Schmidkonz et al.
PET CLINICS (2019)
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems
Andres Kaalep et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Apparent diffusion coefficient of vertebral haemangiomas allows differentiation from malignant focal deposits in whole-body diffusion-weighted MRI
Jessica M. Winfield et al.
EUROPEAN RADIOLOGY (2018)
Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease Correlation With Bone Biopsy Histological and Molecular Features
Raquel Perez-Lopez et al.
INVESTIGATIVE RADIOLOGY (2018)
Total-Body PET: Maximizing Sensitivity to Create New Opportunities for Clinical Research and Patient Care
Simon R. Cherry et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Tumor Uptake of Cu-64-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer
Joanne E. Mortimer et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors
Michael A. Jacobs et al.
ACADEMIC RADIOLOGY (2018)
Patterns of disease progression in patients with local and metastatic breast cancer as evaluated by whole-body magnetic resonance imaging
Michael Kosmin et al.
BREAST (2018)
UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer
Anna Barnes et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Towards enhanced PET quantification in clinical oncology
Habib Zaidi et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Feasibility of state of the art PET/CT systems performance harmonisation
Andres Kaalep et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study
Hebert Alberto Vargas et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
Bone Marrow Metastases: T2-weighted Dixon Spin-Echo Fat Images Can Replace T1-weighted Spin-Echo Images
Yael Maeder et al.
RADIOLOGY (2018)
Positron Emission Tomography/Computed Tomography-Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker forMetastatic Castration-Resistant Prostate Cancer
Josef J. Fox et al.
JAMA ONCOLOGY (2018)
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
D. Planchard et al.
ANNALS OF ONCOLOGY (2018)
The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer
Fabio Zugni et al.
PLOS ONE (2018)
Understanding the Bone in Cancer Metastasis
Jaime Fornetti et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Heterogeneous Flare in Prostate-specific Membrane Antigen Positron Emission Tomography Tracer Uptake with Initiation of Androgen Pathway Blockade in Metastatic Prostate Cancer
Rahul Aggarwal et al.
EUROPEAN UROLOGY ONCOLOGY (2018)
Whole-Body MR Imaging The Novel, Intrinsically Hybrid, Approach to Metastases, Myeloma, Lymphoma, in Bones and Beyond
Frederic E. Lecouvet et al.
PET CLINICS (2018)
Impact of PET reconstruction protocols on quantification of lesions that fulfil the PERCIST lesion inclusion criteria
Joke Devriese et al.
EJNMMI PHYSICS (2018)
Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review
Alessandro Stecco et al.
DIAGNOSTICS (2018)
The addition of whole-body magnetic resonance imaging to body computerised tomography alters treatment decisions in patients with metastatic breast cancer
Michael Kosmin et al.
EUROPEAN JOURNAL OF CANCER (2017)
METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer
Anwar R. Padhani et al.
EUROPEAN UROLOGY (2017)
Pathophysiology of bone metastases from solid malignancies
Philippe Clezardin
JOINT BONE SPINE (2017)
Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer
Jazmin Schwartz et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Initial Experience with Volumetric 68Ga-PSMA I&T PET/CT for Assessment of Whole-Body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate Cancer
Sebastian Schmuck et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
PET Radiomics in NSCLC: state of the art and a proposal for harmonization of methodology
M. Sollini et al.
SCIENTIFIC REPORTS (2017)
Sex Differences and Bone Metastases of Breast, Lung, and Prostate Cancers: Do Bone Homing Cancers Favor Feminized Bone Marrow?
Mary C. Farach-Carson et al.
FRONTIERS IN ONCOLOGY (2017)
Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline
Stephen Lutz et al.
PRACTICAL RADIATION ONCOLOGY (2017)
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
P. E. Postmus et al.
ANNALS OF ONCOLOGY (2017)
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
G. Gebhart et al.
ANNALS OF ONCOLOGY (2016)
Comparison of hybrid Ga-68-PSMA PET/MRI and Ga-68-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer
Martin T. Freitag et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Prognostic significance of increased bone marrow microcirculation in newly diagnosed multiple myeloma: results of a prospective DCE-MRI study
Maximilian Merz et al.
EUROPEAN RADIOLOGY (2016)
Increased microcirculation detected by dynamic contrast-enhanced magnetic resonance imaging is of prognostic significance in asymptomatic myeloma
Jens Hillengass et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers
Ivayla Apostolova et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
Hope S. Rugo et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Targeting the Human Epidermal Growth Factor Receptors with Immuno-PET: Imaging Biomarkers from Bench to Bedside
Gabriela Kramer-Marek et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Biodistribution and Radiation Dosimetry of the Anti-HER2 Affibody Molecule 68Ga-ABY-025 in Breast Cancer Patients
Mattias Sandstrom et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Whole-Body MR Imaging: Musculoskeletal Applications
Frederic E. Lecouvet
RADIOLOGY (2016)
Practical PERCIST: A Simplified Guide to PET Response Criteria in Solid Tumors 1.0
Joo O. Hyun et al.
RADIOLOGY (2016)
Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT
Jens Sorensen et al.
THERANOSTICS (2016)
Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice
Mariana Reza et al.
EUROPEAN UROLOGY FOCUS (2016)
Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients
O. A. Catalano et al.
BRITISH JOURNAL OF CANCER (2015)
Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients
Elske Quak et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases - A correlation study with histology
Maximilian Merz et al.
EUROPEAN JOURNAL OF RADIOLOGY (2015)
Quantification of F-18-Fluorocholine Kinetics in Patients with Prostate Cancer
Eline E. Verwer et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
18F-FDG-PET/MR increases diagnostic confidence in detection of bone metastases compared with 18F-FDG-PET/CT
Andrei Samarin et al.
NUCLEAR MEDICINE COMMUNICATIONS (2015)
Whole-body staging of malignant melanoma. Advantages, limitations and current importance of PET-CT, whole-body MRI and PET-MRI
C. Pfannenberg et al.
RADIOLOGE (2015)
Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care?
D. K. Woolf et al.
ANNALS OF ONCOLOGY (2015)
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone
Ugo De Giorgi et al.
Oncotarget (2015)
Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: A review and position statement by the European Organisation for Research and Treatment of Cancer imaging group
F. E. Lecouvet et al.
EUROPEAN JOURNAL OF CANCER (2014)
Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
Ali Afshar-Oromieh et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18F-FDG PET/CT and MRI
Byung Hyun Byun et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2014)
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Performance of Whole-Body Integrated 18F-FDG PET/MR in Comparison to PET/CT for Evaluation of Malignant Bone Lesions
Matthias Eiber et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Assessment of Simplified Methods to Measure 18F-FLT Uptake Changes in EGFR-Mutated Non-Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor Treatment
Virginie Frings et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Assessment of Treatment Response by Total Tumor Volume and Global Apparent Diffusion Coefficient Using Diffusion-Weighted MRI in Patients with Metastatic Bone Disease: A Feasibility Study
Matthew D. Blackledge et al.
PLOS ONE (2014)
Repeatability of Metabolically Active Tumor Volume Measurements with FDG PET/CT in Advanced Gastrointestinal Malignancies: A Multicenter Study
Virginie Frings et al.
RADIOLOGY (2014)
Whole-Body Diffusion-weighted MR Imaging for Assessment of Treatment Response in Myeloma
Sharon L. Giles et al.
RADIOLOGY (2014)
Comparison of the efficacy and safety of denosumab versus bisphosphonates in breast cancer and bone metastases treatment: A meta-analysis of randomized controlled trials
Xin Wang et al.
ONCOLOGY LETTERS (2014)
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Frueh et al.
ANNALS OF ONCOLOGY (2013)
MRI for response assessment in metastatic bone disease
F. E. Lecouvet et al.
EUROPEAN RADIOLOGY (2013)
Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients
Yihua Wu et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Phase I Study of ARN-509, a Novel Antiandrogen, in the Treatment of Castration-Resistant Prostate Cancer
Dana E. Rathkopf et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
PET imaging of oestrogen receptors in patients with breast cancer
Michel van Kruchten et al.
LANCET ONCOLOGY (2013)
Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
C. Parker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Comparison of 18FDG PET-CT and bone scintigraphy for detection of bone metastases in breast cancer patients. A meta-analysis
Jian Rong et al.
SURGICAL ONCOLOGY-OXFORD (2013)
Meta-analysis: Comparison of F-18 Fluorodeoxyglucose-Positron Emission Tomography and Bone Scintigraphy in the Detection of Bone Metastasis in Patients with Lung Cancer
Ming-Che Chang et al.
ACADEMIC RADIOLOGY (2012)
MRI and neurological findings in patients with spinal metastases
M. D. Switlyk et al.
ACTA RADIOLOGICA (2012)
Imaging bone metastases in breast cancer: evidence on comparative test accuracy
N. Houssami et al.
ANNALS OF ONCOLOGY (2012)
Synthesis and in vitro evaluation of 68Ga-DOTA-4-FBn-TN14003, a novel tracer for the imaging of CXCR4 expression
Ute Hennrich et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
A meta-analysis of 18FDG-PET-CT, 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with lung cancer
Xinhua Qu et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Can Whole-body Magnetic Resonance Imaging with Diffusion-weighted Imaging Replace Tc 99m Bone Scanning and Computed Tomography for Single-step Detection of Metastases in Patients with High-risk Prostate Cancer?
Frederic E. Lecouvet et al.
EUROPEAN UROLOGY (2012)
Prolonged androgen deprivation leads to downregulation of androgen receptor and prostate-specific membrane antigen in prostate cancer cells
Tiancheng Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate Cancer
Elizabeth R. Dennis et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
PET of HER2-Positive Pulmonary Metastases with 18F-ZHER2:342 Affibody in a Murine Model of Breast Cancer: Comparison with 18F-FDG
Gabriela Kramer-Marek et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Bony metastases: assessing response to therapy with whole-body diffusion MRI
A.R. Padhani et al.
CANCER IMAGING (2012)
The CT flare response of metastatic bone disease in prostate cancer
Christina Messiou et al.
ACTA RADIOLOGICA (2011)
Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organs
Shi Wei et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2011)
A novel PET tracer for the imaging of αvβ3 and αvβ5 integrins in experimental breast cancer bone metastases
Ute Mühlhausen et al.
Contrast Media & Molecular Imaging (2011)
Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastases
Maximilian Merz et al.
EUROPEAN JOURNAL OF CANCER (2011)
Assessing response in bone metastases in prostate cancer with diffusion weighted MRI
C. Messiou et al.
EUROPEAN RADIOLOGY (2011)
Diffusion MR Imaging for Monitoring of Treatment Response
Anwar R. Padhani et al.
MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA (2011)
Drug-Induced Vessel Remodeling in Bone Metastases as Assessed by Dynamic Contrast Enhanced Magnetic Resonance Imaging and Vessel Size Imaging: A Longitudinal In vivo Study
Tobias Baeuerle et al.
CLINICAL CANCER RESEARCH (2010)
Bone metastasis in patients with non-small cell lung cancer: The diagnostic role of F-18 FDG PET/CT
Ningbo Liu et al.
EUROPEAN JOURNAL OF RADIOLOGY (2010)
Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa)
F. E. Lecouvet et al.
EUROPEAN RADIOLOGY (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Imaging metastatic bone disease from carcinoma of the prostate
C. Messiou et al.
BRITISH JOURNAL OF CANCER (2009)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Whole-body MRI for the staging and follow-up of patients with metastasis
Gerwin P. Schmidt et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
Imaging response to systemic therapy for bone metastases
Tobias Baeuerle et al.
EUROPEAN RADIOLOGY (2009)
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Richard L. Wahl et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Osteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer (NSCLC) Patients Receiving Bevacizumab in Addition to Standard Chemotherapy
Yelena Krupitskaya et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Diffusion-weighted MR Imaging: Adjunct or Alternative to T1-weighted MR Imaging for Prostate Carcinoma Bone Metastases?
Frederic E. Lecouvet et al.
RADIOLOGY (2009)
Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT
Gerwin P. Schmidt et al.
EUROPEAN JOURNAL OF RADIOLOGY (2008)
Ensuring the right PET scan for the right patient
Stephen G. Spiro et al.
LUNG CANCER (2008)
18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer:: A systematic review
Yee C. Ung et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer:: Diagnostic and cost-effectiveness and comparison with current detection strategies
Frederic E. Lecouvet et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Bone sialoprotein is predictive of bone metastases in resectable non-small-cell lung cancer: A retrospective case-control study
Mauro Papotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Basic mechanisms responsible for osteolytic and osteoblastic bone metastases
Theresa A. Guise et al.
CLINICAL CANCER RESEARCH (2006)
Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases
B Tombal et al.
PROSTATE (2005)
In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment
DA Sipkins et al.
NATURE (2005)
Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors
JE Brown et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer
H Schirrmeister et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
RE Coleman
CANCER TREATMENT REVIEWS (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer:: A direct comparison of fluorescence in situ hybridization and immunohistochemistry
G Pauletti et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
